John Curran

Experience

• 

  Athena Diagnostics, Inc.

  Aug 2000 - Apr 2004

  Scientist II
• 

  Correlagen Diagnostics

  Apr 2004 - Sept 2010

  Director of Laboratory Operations

  I was chosen as the 2nd hire, assisting in the development and validation of next generation sequencing product, Cardio Gene Scan (CGS), the first commercially assigned assay of its size and type. I served a crucial role in partnering with LabCorp to create assays to detect mutations in MMR genes for the diagnosis of hereditary nonpolyposis colon cancer (HNPCC), serving as a critical component of the decision by LabCorp to acquire Correlagen. I leveraged my natural leadership skills to mentor 9 direct reports including technologists, PhD scientists, regulatory and automated specialists to position organization as an industry leader in turnaround time. Show less

• 

  Foundation Medicine

  Oct 2010 - Jun 2015

  Director, Central Laboratory

  Throughout this role, I pioneered the growth of CLIA lab operations through recruitment and direction of 30 personnel tasked with performing next generation testing and reporting. As employee #17, I established new 6K sq. ft. next generation sequencing (NGS) lab and migrating to new facility with zero impact on daily processing functions. I secured numerous state approvals in MA, NY, RI, MD, FL, CA, and PA as well as CLIA and CAP accreditations. I also played a primary role in forging and managing strategic partnerships with 20+ pharmaceutical entities including Novartis, Bayer, JnJ, Clovis, and Roche. I worked cross-functionally to initiate an automated solution for developing NGS assays over three lines with 12 HiSeq 2500s. Show less

• 

  Neon Therapeutics

  Jun 2015 - Aug 2019

  Director, Laboratory and Facilities Operations

  I was recruited as hire #7, maintaining accountability for architecting and managing sequencing operations at an external vendor. I coordinated supply chain functions and sample tracking activities for the NEO-PV-01, 02 and 03 clinical trials. Alliance Manager with the peptide CRO for GMP manufacturing of drug product. I directed client audits through extensive analysis of client QC data to ensure quality of project deliverables. I led all facets of operations including chemistry and biology functions, verifying availability of equipment and supplies and ensuring proper storage of samples. Show less

• 

  BostonGene

  Aug 2019 - Jan 2024

  I was called upon as the first hire to launch and grow a CLIA laboratory from the ground up. I effectively provided strategic direction throughout site selection and vendor negotiation processes. I steered the procurement of CLIA and CAP accreditations as well as MA, PA, CA, RI, MD, and NY licenses to remain competitive within an ever-changing industry. I directly supervise 10 laboratory technologists with additional regulatory oversight for all aspects of clinical sample processing, comprising an additional 50+ testing personnel. I am often called upon to serve as a key contributor and project leader on multiple academic/biopharma projects in addition to clinical trials. Show less

  • Laboratory Director and VP, Laboratory Operations

    Mar 2023 - Jan 2024

  • VP, Laboratory Operations

    Aug 2019 - Mar 2023
• 

  Pear Bio

  Jan 2024 - now

  • COO & Laboratory Director

    May 2024 - now

  • Laboratory Director and Head, US Operations

    Jan 2024 - May 2024